- Home
- CSTE vs TARA Comparison
CSTE vs TARA Comparison
Compare CSTE & TARA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CSTE
- TARA
- Stock Information
- Founded
- CSTE 1987
- TARA N/A
- Country
- CSTE Israel
- TARA United States
- Employees
- CSTE N/A
- TARA N/A
- Industry
- CSTE Building Materials
- TARA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CSTE Industrials
- TARA Health Care
- Exchange
- CSTE Nasdaq
- TARA Nasdaq
- Market Cap
- CSTE 131.2M
- TARA 136.3M
- IPO Year
- CSTE 2012
- TARA N/A
- Fundamental
- Price
- CSTE $2.43
- TARA $4.58
- Analyst Decision
- CSTE Strong Buy
- TARA Strong Buy
- Analyst Count
- CSTE 1
- TARA 4
- Target Price
- CSTE $6.00
- TARA $22.67
- AVG Volume (30 Days)
- CSTE 84.2K
- TARA 216.2K
- Earning Date
- CSTE 03-05-2025
- TARA 03-05-2025
- Dividend Yield
- CSTE N/A
- TARA N/A
- EPS Growth
- CSTE N/A
- TARA N/A
- EPS
- CSTE N/A
- TARA N/A
- Revenue
- CSTE $443,221,000.00
- TARA N/A
- Revenue This Year
- CSTE $5.06
- TARA N/A
- Revenue Next Year
- CSTE $4.73
- TARA N/A
- P/E Ratio
- CSTE N/A
- TARA N/A
- Revenue Growth
- CSTE N/A
- TARA N/A
- 52 Week Low
- CSTE $2.43
- TARA $1.60
- 52 Week High
- CSTE $6.81
- TARA $10.48
- Technical
- Relative Strength Index (RSI)
- CSTE 19.53
- TARA 57.21
- Support Level
- CSTE $2.68
- TARA $4.41
- Resistance Level
- CSTE $3.12
- TARA $4.81
- Average True Range (ATR)
- CSTE 0.20
- TARA 0.27
- MACD
- CSTE -0.02
- TARA 0.06
- Stochastic Oscillator
- CSTE 0.00
- TARA 78.01
About CSTE Caesarstone Ltd.
Caesarstone Ltd manufactures engineered quartz surfaces. Its products include engineered quartz and porcelain slabs, which are used as kitchen countertops in renovation and remodeling, and residential construction. It also has other applications, including vanity tops, wall panels, backsplashes, floor tiles, stairs, and other interior surfaces that are used in various residential and non-residential applications. The company sells its products under the Caesarstone brand. Caesarstone's geographical segments are the United States, Canada, Latin America, Australia, Asia, Israel, and EMEA(Europe, Middle East, Africa).
About TARA Protara Therapeutics Inc.
Protara Therapeutics Inc is committed to identifying and advancing transformative therapies for people with cancer and rare diseases. The company discovers, develops, and delivers breakthrough therapies to people who have limited treatment options. Its portfolio includes its program, TARA-002, being developed for the treatment of lymphatic malformations, and intravenous (IV) choline chloride, a phospholipid substrate replacement therapy for the treatment of intestinal failure associated liver disease (IFALD).